AAAAAA
Results: 1-25/44
Authors:
Shoenfeld, Y
Sherer, Y
George, Y
Harats, D
Citation: Y. Shoenfeld et al., beta 2-glycoprotein I in human and murine atherosclerosis, ISR MED ASS, 3(2), 2001, pp. 85-87
Authors:
Sherer, Y
Wu, R
Krause, I
Peter, JB
Shoenfeld, Y
Citation: Y. Sherer et al., Antiphospholipid antibody levels in intravenous immunoglobulin (IVIg) preparations, LUPUS, 10(8), 2001, pp. 568-570
Authors:
Sherer, Y
Bitzur, R
Cohen, H
Shaish, A
Varon, D
Shoenfeld, Y
Harats, D
Citation: Y. Sherer et al., Mechanisms of action of the anti-atherogenic effect of magnesium: lessons from a mouse model, MAGNES RES, 14(3), 2001, pp. 173-179
Authors:
Sherer, Y
Tenenbaum, A
Blank, M
Shemesh, J
Harats, D
Fisman, EZ
Praprotnik, S
Motro, M
Shoenfeld, Y
Citation: Y. Sherer et al., Autoantibodies to oxidized low-density lipoprotein in coronary artery disease, AM J HYPERT, 14(2), 2001, pp. 149-154
Authors:
Renaudineau, Y
Grunebaum, E
Krause, I
Praprotnik, S
Revelen, R
Youinou, P
Blanks, M
Gilburd, B
Sherer, Y
Luderschmidt, C
Eldor, A
Weksler, B
Gershwin, EM
Shoenfeld, Y
Citation: Y. Renaudineau et al., Anti-endothelial cell antibodies (AECA) in systemic sclerosis - Increased sensitivity using different endothelial cell substrates and association with other autoantibodies, AUTOIMMUN, 33(3), 2001, pp. 171-179
Authors:
Mishal, J
Leibovici, O
Bregman, L
London, D
Yoffe, B
Sherer, Y
Citation: J. Mishal et al., Huge renal arteriovenous malformation mimicking a simple para-pelvic cyst, UROL INTERN, 66(1), 2001, pp. 49-50
Authors:
Mishal, J
Sherer, Y
Levin, Y
Katz, D
Embon, E
Citation: J. Mishal et al., Two-stage evaluation and intervention program for control of methicillin-resistant Staphylococcus aureus in the hospital setting, SC J IN DIS, 33(7), 2001, pp. 498-501
Authors:
Sherer, Y
Levy, Y
Langevitz, P
Rauova, L
Fabrizzi, F
Shoenfeld, Y
Citation: Y. Sherer et al., Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases, PHARMACOL, 62(3), 2001, pp. 133-137
Authors:
Shoenfeld, Y
Blank, M
Sherer, Y
Citation: Y. Shoenfeld et al., Induction and treatment of the antiphospholipid syndrome - lessons from animal models, EUR J CL IN, 31(8), 2001, pp. 736-740
Authors:
Sherer, Y
Tenenbaum, A
Praprotnik, S
Shemesh, J
Blank, M
Fisman, EZ
Harats, D
George, J
Levy, Y
Peter, JB
Motro, M
Shoenfeld, Y
Citation: Y. Sherer et al., Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, beta-2-glycoprotein-1, and oxidized LDL antibodies, CARDIOLOGY, 95(1), 2001, pp. 20-24
Authors:
Sherer, Y
Levy, Y
Shoenfeld, Y
Citation: Y. Sherer et al., Intravenous immunoglobulin therapy of antiphospholipid syndrome, RHEUMATOLOG, 39(4), 2000, pp. 421-426
Authors:
Sherer, Y
Shoenfeld, Y
Citation: Y. Sherer et Y. Shoenfeld, Antiphospholipid syndrome: insights from animal models, CURR OPIN H, 7(5), 2000, pp. 321-324
Authors:
Sherer, Y
Shoenfeld, Y
Citation: Y. Sherer et Y. Shoenfeld, The idiotypic network in antinuclear-antibody-associated diseases, INT A AL IM, 123(1), 2000, pp. 10-15
Authors:
Sharabi, Y
Grossman, E
Sherer, Y
Shaish, A
Levkovitz, H
Bitzur, R
Harats, D
Citation: Y. Sharabi et al., The effect of renin-angiotensin axis inhibition on early atherogenesis in LDL-receptor-deficient mice, PATHOBIOLOG, 68(6), 2000, pp. 270-274
Authors:
Sherer, Y
Shoenfeld, Y
Shaish, A
Levkovitz, H
Bitzur, R
Harats, D
Citation: Y. Sherer et al., Suppression of atherogenesis in female low-density lipoprotein receptor knockout mice following magnesium fortification of drinking water: The importance of diet, PATHOBIOLOG, 68(2), 2000, pp. 93-98
Authors:
Sherer, Y
Livneh, A
Levy, Y
Shoenfeld, Y
Langevitz, P
Citation: Y. Sherer et al., Dermatomyositis and polymyositis associated with the antiphospholipid syndrome - a novel overlap syndrome, LUPUS, 9(1), 2000, pp. 42-46
Authors:
Mishal, J
Sherer, Y
Magen, E
Lugasi, G
Citation: J. Mishal et al., Transient polycythemia and multi-organ failure due to acute alcohol ingestion, ANN HEMATOL, 79(10), 2000, pp. 596-597
Authors:
Mishal, J
Lebovici, O
Bregman, L
London, D
Yoffe, B
Sherer, Y
Citation: J. Mishal et al., Huge renal arteriovenous malformation mimicking simple parapelvic cyst, CLIN IMAG, 24(3), 2000, pp. 166-168
Authors:
Terryberry, JW
Shoenfeld, Y
Sherer, Y
Levy, Y
Fabrizzi, F
Ahmed, A
Peter, JB
Citation: Jw. Terryberry et al., Detection of antibodies to gangliosides and glycolipids in various intravenous immunoglobulin (IVIg) preparations, IMMUNOL INV, 29(3), 2000, pp. 337-347
Authors:
Shoenfeld, Y
Sherer, Y
George, J
Harats, D
Citation: Y. Shoenfeld et al., Autoantibodies associated with atherosclerosis, ANN MED, 32, 2000, pp. 37-40
Authors:
Levy, Y
Sherer, Y
Langevitz, P
Lorber, M
Rotman, P
Fabrizzi, F
Shoenfeld, Y
Citation: Y. Levy et al., Skin score decrease in systemic sclerosis patients treated with intravenous immunoglobulin - A preliminary report, CLIN RHEUMA, 19(3), 2000, pp. 207-211
Authors:
Levin, Y
Sherer, Y
Bibi, H
Schlesinger, M
Hay, E
Citation: Y. Levin et al., Rare Jatropha multifida intoxication in two children, J EMERG MED, 19(2), 2000, pp. 173-175
Authors:
Levy, Y
Sherer, Y
Mathieu, A
Cauli, A
Passiu, G
Sanna, G
Janackovic, Z
Blank, M
Shoenfeld, Y
Citation: Y. Levy et al., Anti-cardiolipin antibody from a patient with antiphospholipid syndrome (APS) recognizes only an epitope expressed by cardiolipin/beta(2)-glycoprotein-I (beta(2)GPI) complex and induces APS, CLIN EXP RH, 18(4), 2000, pp. 479-484
Authors:
Shoenfeld, Y
Aharon-Maor, A
Sherer, Y
Citation: Y. Shoenfeld et al., Vaccination as an additional player in the mosaic of autoimmunity, CLIN EXP RH, 18(2), 2000, pp. 181-184
Authors:
Sherer, Y
Shoenfeld, Y
Citation: Y. Sherer et Y. Shoenfeld, Idiotypic network dysregulation - A common etiopathogenesis of diverse autoimmune diseases, APPL BIOC B, 83(1-3), 2000, pp. 155-162